Nanome became the first VR software company to launch an immersive real-time collaboration platform for scientific discovery in 2015. The software environment accelerates scientific decision making by allowing users to visualize, modify, and simulate biological and chemical compounds, facilitating effective communication of data and integrating with existing computational chemistry workflows. Nanome continues to grow by a partnership with Fujitsu to bring his VR tool in Japan. Source: VR startup in US brings immersive drug design software…"VR startup in US brings immersive drug design software to Japan"
This VR simulation helps people to recognize what is a overdose and how to react. This application need only a smartphone and a cardboard. Researchers at the University of Pennsylvania have developed a virtual-reality video that trains people to give overdose victims naloxone, the lifesaving opioid-reversal medicine. And a study the researchers conducted shows the virtual training works as effectively as an in-person session. Source: Researchers use virtual reality to train bystanders to respond to overdoses…"Researchers use virtual reality to train bystanders to respond to overdoses"
In this article, you will find many examples where “in silico” methods and computing can change biology. In drug discovery, it’s really interesting to see that it allows us to make multiple virtual assays and only synthesize and test only promising compounds. It’s a new era of modeling and simulation, which is accelerating discovery for drugs, vaccines, medical devices, materials, and many other products. For years, simulations have been used for physical systems, to cheaply…"Virtual Medicine for Real Patients"
As you may known, 3D cell environments are very relevant to test drugs as its mimic human body much more precisely than 2D experiments (It’s why we develop BIOMIMESYS® in HCS Pharma). But to understand drugs action and efficacy you also need 3D visualization tools. In this article, you will discover how a team from UNSW Medicine and Children’s Cancer Institute use immersive devices to explore data. They can literally “walk” inside tumors to see…"Virtual reality allows multiple scientists to ‘walk’ through cancer cells"
At Novartis, virtual reality is used to understand complex interactions between molecules. It’s a way to facilitate communication between chemist and biologist about drug design and protein’s interactions. Viktor Hornak, an investigator in the Global Discovery Chemistry department at the Novartis Institutes for BioMedical Research (NIBR), is driving an effort to adapt VR tools for use in the drug design process. He and his colleagues recognize a potential for VR to help drug hunters more quickly…"Bringing virtual reality to the lab at Novartis"